News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2023.07.14
Report on the Courtesy Visit of the Delegation from Beijing Municipal Development Zone to Shonan iPark and our Company
-
2023.07.12
Request for Change of Address and Other Changes in Registered Matters in the Shareholders’ Register
-
2023.06.28
Notice of Resolutions of the 21st Ordinary General Meeting of Shareholders
-
2023.06.21
Notice of Completion of Investigational Drug Administration in Phase III Clinical Trial of LT-5001
-
2023.06.16
Report on Participation in BIO International Convention 2023 Boston
-
2023.06.16
第21回定時株主総会会場に関するお知らせ
-
2023.06.08
Meeting between Mr. Tse Eric, the new Chairman of Beijing Tide Pharmaceutical Co., LTD., and our CEO
-
2023.06.07
Notice of Joint Research Agreement with Hokkaido University
-
2023.05.25
Notice of Business Consignment Agreement with a Japanese Company Seeking to Develop Business in China
-
2023.05.08
Notice of the start of Phase III clinical trial (investigator-initiated clinical trial) of LT-5001